UK markets closed
NIKKEI 225
38,814.56 +94.06 (+0.24%) HANG SENG
17,941.78 -170.82 (-0.94%) CRUDE OIL
78.50 +0.05 (+0.06%) GOLD FUTURES
2,346.00 -3.10 (-0.13%) DOW
38,589.16 -57.94 (-0.15%) Bitcoin GBP
52,592.03 +546.35 (+1.05%)
Nektar Therapeutics (ITH.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:50PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 200.50M |
| Enterprise value | 37.38M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.59 |
| Price/book (mrq) | 1.77 |
| Enterprise value/revenue | 0.45 |
| Enterprise value/EBITDA | -5.43 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.71 |
| 52-week change 3 | 116.25% |
| S&P500 52-week change 3 | 23.76% |
| 52-week high 3 | 1.6870 |
| 52-week low 3 | 0.3901 |
| 50-day moving average 3 | 1.3630 |
| 200-day moving average 3 | 0.7598 |
Share statistics
| Avg vol (3-month) 3 | 841 |
| Avg vol (10-day) 3 | 1.8k |
| Shares outstanding 5 | 184.02M |
| Implied shares outstanding 6 | 190.22M |
| Float 8 | 163.24M |
| % held by insiders 1 | 1.09% |
| % held by institutions 1 | 61.88% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -195.02% |
| Operating margin (ttm) | -159.21% |
Management effectiveness
| Return on assets (ttm) | -17.31% |
| Return on equity (ttm) | -95.68% |
Income statement
| Revenue (ttm) | 90.17M |
| Revenue per share (ttm) | 0.47 |
| Quarterly revenue growth (yoy) | 0.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -125.54M |
| Net income avi to common (ttm) | -175.84M |
| Diluted EPS (ttm) | -0.8500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 289.24M |
| Total cash per share (mrq) | 1.58 |
| Total debt (mrq) | 231.94M |
| Total debt/equity (mrq) | 183.05% |
| Current ratio (mrq) | 6.10 |
| Book value per share (mrq) | 0.69 |
Cash flow statement
| Operating cash flow (ttm) | -188.58M |
| Levered free cash flow (ttm) | -66.6M |
© 2024 Yahoo. All rights reserved.